Iteos Therapeutics Inc (NASDAQ:ITOS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Jade Biosciences, Inc. (Director · Jun 29, 2021 – Jun 17, 2024 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Jun 9, 2022 – Jun 9, 2022 · Past |
| Ansbert Gadicke Other companies: Cullinan Therapeutics, Inc. (Director · Jan 7, 2021 – Jun 22, 2022 · Past); Kalaris Therapeutics, Inc. (Director · Jul 29, 2020 – Jul 28, 2022 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Jun 1, 2023 · Past); Chiasma Inc (Director · Jul 15, 2015 – Jun 9, 2016 · Past); Verastem, Inc. (Director · Jan 26, 2012 – Mar 6, 2012 · Past); Radius Health, Inc. (Director · May 17, 2011 – Feb 17, 2017 · Past) | Director · Jul 23, 2020 – Jul 28, 2020 · Past |
| Robert Iannone Other companies: Pliant Therapeutics, Inc. (Director · Since at least Jul 9, 2026); Autolus Therapeutics plc (Chair of the Research & Development Committee · Since at least Mar 18, 2026); Jazz Pharmaceuticals plc (EVP, Global Head of R&D & CMO · Since at least May 29, 2019); Jounce Therapeutics Inc (Director · Jan 21, 2020 – May 3, 2023 · Past); Immunomedics Inc (CHIEF MEDICAL OFFICER · Apr 12, 2018 – Mar 14, 2019 · Past) | Director · Apr 29, 2021 – Jun 11, 2024 · Past |
| Tim Van Hauwermeiren Other companies: argenx SE (Co-Founder, Non-Independent Non-Executive Director and Chairperson of the Board · Since at least May 6, 2026); Denali Therapeutics Inc. (Director · Since at least Nov 4, 2025); Lexeo Therapeutics, Inc. (Board Member · Since at least Jul 5, 2024); RayzeBio, Inc. (Director · Nov 1, 2023 – Feb 26, 2024 · Past) | Director · Jul 23, 2020 – May 13, 2025 · Past |
| David L. Hallal Other companies: Scholar Rock Holding Corporation (Chairman and Chief Executive Officer · Since at least Jun 27, 2024); Kalaris Therapeutics, Inc. (Director · Since at least Jun 6, 2024); Seer, Inc. (Director · Jun 12, 2024 – Jun 12, 2024 · Past) | Director · Since at least Jun 11, 2024 |
| Jill Desimone Other companies: Praxis Precision Medicines, Inc. (Director · Since at least May 23, 2022); Kinnate Biopharma Inc (Director · Mar 1, 2023 – Apr 3, 2024 · Past); Oncternal Therapeutics Inc (Director · Jan 4, 2023 – Jun 20, 2024 · Past) | Director · Mar 7, 2024 – Jun 11, 2024 · Past |
| Aaron I Davis Other companies: Tango Therapeutics, Inc. (Director · Jun 8, 2022 – Aug 11, 2023 · Past); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past) | Director · Jul 23, 2020 – Jun 11, 2024 · Past |
| Matthew Gall Other companies: Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Apr 15, 2026); Kalaris Therapeutics, Inc. (Chief Financial Officer · Since at least Nov 3, 2025) | Chief Financial Officer · Since at least Jul 23, 2020 |
| Matthew Roden Other companies: Aktis Oncology, Inc. (President, Chief Executive Officer · Since at least Jan 8, 2026); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past) | Director · Nov 9, 2020 – Jun 9, 2022 · Past |
| Michel Detheux Other companies: Vor Biopharma Inc. (Member of the Audit Committee · Since at least Jul 16, 2025) | Chief Executive Officer, Director · Since at least Jul 23, 2020 |
| Priyanka Belawat Other companies: BioAtla, Inc. (Director · Dec 15, 2020 – Dec 15, 2020 · Past) | Director · Jul 23, 2020 – Jul 23, 2020 · Past |
| Tony W Ho Other companies: CRISPR Therapeutics AG (Executive VP, Head of R&D · Aug 1, 2017 – Dec 3, 2021 · Past) | Director · Apr 29, 2021 – Jun 11, 2024 · Past |
| David Feltquate | Chief Medical Officer · Since at least Jul 31, 2024 |
| David K Lee | Director · Since at least Dec 5, 2023 |
| Joanne Jenkins Lager | Chief Medical Officer · Jul 23, 2020 – Mar 9, 2023 · Past |
| Matthew Call | Chief Operating Officer · Since at least Jul 23, 2020 |
| Yvonne McGrath | Chief Scientific Officer · Since at least Mar 1, 2021 |